Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
“the infection of a basal stem cell (rather than a basal transiently amplifying cell) and that the longevity of the stem cells is a key factor in the formation of a persistent lesion [3,50,91,92].”
BackgroundInfluentialSelf-citationRegulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
“The importance of MDM2 and MDM4 antagonists In many tumours that express wild-type p53, the function of p53 can be compromised by viral oncogenes such as the papillomavirus E6 and adenovirus E1B proteins that induce p53 degradatio”
BackgroundThe natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
“This requires a change in splice site usage rather than the activation of new promoters, leading to an elevation in transcripts that initiate at the late promoter (p670 in HPV 16) and which terminate at the late (rather than the early) polyadenylation site [85], an event that is facilitated by the higher levels of E2…”
BackgroundInfluentialSelf-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationCellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“gov/cancertopics/types/head-and-neck/">squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotei”
BackgroundHuman Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
“life cycle is no longer supported and viral episomes are lost (reviewed in [83]).”
BackgroundInfluentialSelf-citationPathology and epidemiology of HPV infection in females
Stanley, M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.024 · Cited by 470
“Late gene expression is either lost or significantly reduced, the viral DNA sequences may be integrated into the host genome, and expression of the E6 and E7 oncogenes is deregulated with the expression of these oncoproteins throughout the epithelium [32].”
BackgroundA Specificity Map for the PDZ Domain Family
Tonikian, R., Zhang, Y., Sazinsky, S. L., Currell, B., Yeh, J.-H., Reva, B., Held, H. A., Appleton, B. A., Evangelista, M., Wu, Y., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060239 · Cited by 476
“The induction of hyperproliferation is likely to be advantageous for viral replication in general, and thus, it appears that the ability to disrupt polarity by interference with SCRIB PDZ domain complexes is a crucial factor in conferring high pathogenicity to many viruses, including HPV, HTLV, and influenza A.”
BackgroundResultInfluentialSegal, B. H., Herbrecht, R., Stevens, D. A., Ostrosky‐Zeichner, L., Sobel, J., Viscoli, C., Walsh, T. J., Maertens, J., Patterson, T. F., Perfect, J. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590566 · Cited by 468
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3728 · Cited by 386
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 360
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
Dotto, G. P., & Rustgi, A. K. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.004 · Cited by 319
Molecular mechanisms of viral oncogenesis in humans
Krump, N. A., & You, J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0064-6 · Cited by 295
Does the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou, M., Mitra, A., & Moscicki, A.-B. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.004 · Cited by 282
“Final pathways to cancer result in interference with telomerase activity and viral integration—although a percent of cancers are found to have episomal HPV DNA only.(20) HPV E6 and E7 are known oncoproteins, which control fundamental carcinogenic events including proliferation, senescence, and apoptosis.”
BackgroundCuschieri, K., & Wentzensen, N. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0306 · Cited by 273
“This deregulation is evidenced particularly by the presence of E7 throughout the epithelium and in the surface layers (16).”
BackgroundAssociation of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
Carter, J. J., Paulson, K. G., Wipf, G. C., Miranda, D., Madeleine, M. M., Johnson, L. G., Lemos, B. D., Lee, S., Warcola, A. H., Iyer, J. G., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp332 · Cited by 238
HPV - immune response to infection and vaccination
Stanley, M. (2010) · Infectious Agents and Cancer · doi:10.1186/1750-9378-5-19 · Cited by 232
“However, if viral infection becomes persistent then the probability of molecular accidents deregulating control of E6/E7 oncogene expression in mitotically active cells will increase [17] and neoplastic progression starts.”
BackgroundSpoden, G., Freitag, K., Husmann, M., Boller, K., Sapp, M., Lambert, C., & Florin, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003313 · Cited by 223
“Human papillomaviruses (HPVs) are nonenveloped viruses with a double-stranded circular DNA genome [1].”
BackgroundOlsson, S.-E., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Hseon Tay, E., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9515 · Cited by 217
“The alternative explanation being that some people may have low-level persistent HPV infections (also known as latency) that are able to remain undetected due to issues of host immune competence.(8) Therefore, in these subjects, apparent reinfection could be a re-emergence of a low-level persistent infection that was…”
BackgroundZhen, S., Hua, L., Takahashi, Y., Narita, S., Liu, Y.-H., & Li, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.014 · Cited by 219
“It affects nearly half a million women each year, claiming a quarter of a million lives [1,2].”
Cui, H., Hayashi, A., Sun, H.-S., Belmares, M. P., Cobey, C., Phan, T., Schweizer, J., Salter, M. W., Wang, Y. T., Tasker, R. A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1464-07.2007 · Cited by 205
“, 2002), cancers (Kanamori et al., 2003; Hirai et al., 2004; Doorbar, 2006), infection (Excoffon et al.”
BackgroundInterplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections
Torcia, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020266 · Cited by 202
“Generally, HPV infects the basal layer of the cervical squamous epithelium, where viral genomes persist as episomes at low-copy numbers [40].”
BackgroundHPV: Molecular pathways and targets
Gupta, S., Kumar, P., & Das, B. C. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.03.003 · Cited by 195
“…is the non-coding region called long control region (LCR) or upstream regulatory region (URR) which contains the cis-elements containing a DNA replication origin, transcriptional regulatory sequence and one/more promoters, which regulate the expression of E6 and E7 oncoproteins (Doorbar 2006).”
BackgroundSasagawa, T., Takagi, H., & Makinoda, S. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0485-5 · Cited by 200
“bition of Rb and p53 functions [8].”
BackgroundInfluentialCurty, G., de Carvalho, P. S., & Soares, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010222 · Cited by 180
“There are currently over 200 different HPV types described that infect epithelial cells [2], of which around 40 have tropism to mucosal tissues.”
BackgroundHuman Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
Clarke, M. A., Wentzensen, N., Mirabello, L., Ghosh, A., Wacholder, S., Harari, A., Lorincz, A., Schiffman, M., & Burk, R. D. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0905 · Cited by 183
Karim, R., Tummers, B., Meyers, C., Biryukov, J. L., Alam, S., Backendorf, C., Jha, V., Offringa, R., van Ommen, G.-J. B., Melief, C. J. M., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003384 · Cited by 180
“the primary target for hrHPV [2] where it establishes an infection that”
BackgroundAubin, F., Prétet, J., Jacquard, A., Saunier, M., Carcopino, X., Jaroud, F., Pradat, P., Soubeyrand, B., Leocmach, Y., Mougin, C., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590560 · Cited by 189
“This allows a careful regulation of viral genes (in particular, E6 and E7 oncogenes are repressed), leading to the production of virions in the most differentiated layer of the epithelium [27].”
BackgroundFOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
“Cervix cancer often results from HPV16 infection (Baseman and Koutsky, 2005; Burk et al., 2009; Doorbar, 2006; Fehrmann and Laimins, 2003; Feller et al., 2009; Hebner and Laimins, 2006; Jayshree et al., 2009; Kisseljov et al., 2008; Lehoux et al., 2009; Lizano et al., 2009; Longworth and Laimins,…”
BackgroundHuman papillomaviruses, cervical cancer and cell polarity
Thomas, M., Narayan, N., Pim, D., Tomaić, V, Massimi, P., Nagasaka, K., Kranjec, C., Gammoh, N., & Banks, L. (2008) · Oncogene · doi:10.1038/onc.2008.351 · Cited by 163
“As can be seen from Figure 1, HPVs are thought to infect the basal cells of the epithelium through microtraumas, and as the cells differentiate and stratify there is coordinate expression of the viral gene products, ultimately resulting in the generation of new infectious virus particles (Doorbar, 2006).”
BackgroundKlingelhutz, A. J., & Roman, A. (2012) · Virology · doi:10.1016/j.virol.2011.12.018 · Cited by 166
“It has been postulated that the intracellular environment of the basal cells in this region, or the reserve cells which give rise to these basal cells, may somehow limit completion of the productive life cycle (Doorbar, 2006).”
BackgroundWang, H.-K., Duffy, A. A., Broker, T. R., & Chow, L. T. (2009) · Genes & Development · doi:10.1101/gad.1735109 · Cited by 170
“However, mutational analyses of the E4 gene have not resolved its role in viral DNA amplification (Nakahara et al. 2005; Wilson et al. 2005; Fang et al. 2006a).”
BackgroundPathogenesis of human papillomavirus‐associated mucosal disease
Groves, I. J., & Coleman, N. (2015) · The Journal of Pathology · doi:10.1002/path.4496 · Cited by 164
“The ability of HPV to target basal stem cells is also likely to provide one mechanism by which persistent infection is established in some individuals (Figure 1) [16].”
BackgroundVaginal microbiome and cervical cancer
Kyrgiou, M., & Moscicki, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.005 · Cited by 184
Liu, Y., Guo, J.-Z., Liu, Y., Wang, K., Ding, W., Wang, H., Liu, X., Zhou, S., Lu, X.-C., Yang, H.-B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06841-7 · Cited by 165
Development of Peptide-Based Vaccines for Cancer
Abd-Aziz, N., & Poh, C. L. (2022) · Journal of Oncology · doi:10.1155/2022/9749363 · Cited by 152
“Gardasil and Cervarix, on the other hand, are generated from VLPs consisting of the single capsid protein L1, which provides protection against HPV types 16 and 18 [4].”
BackgroundThe role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
Lassen, P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.022 · Cited by 163
“Viral particles are then formed progressively as the basal cells differentiate and are eventually released when the cells reach the outer layer of the epithelium [11–13].”
BackgroundLazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
“The viral DNA is associated with cellular histones to form a “minichromosome” (51) and is enclosed in an icosahedral capsid consisting of 72 capsomers (39, 54).”
BackgroundGiant magnetoresistive biochip for DNA detection and HPV genotyping
Xu, L., Yu, H., Akhras, M. S., Han, S.-J., Osterfeld, S., White, R. L., Pourmand, N., & Wang, S. X. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.03.030 · Cited by 163
“Infection with HPV is associated with various forms of cancers, including cervical cancer (Doorbar, 2006).”
BackgroundKarim, R., Meyers, C., Backendorf, C., Ludigs, K., Offringa, R., van Ommen, G.-J. B., Melief, C. J. M., van der Burg, S. H., & Boer, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017848 · Cited by 158
“The replication cycle of the virus is tightly coupled to the differentiation of basal KCs to stratified squamous epithelia and it is well known that HPVs inhibit KC differentiation [11].”
BackgroundTetraspanin CD151 Mediates Papillomavirus Type 16 Endocytosis
Scheffer, K. D., Gawlitza, A., Spoden, G. A., Zhang, X. A., Lambert, C., Berditchevski, F., & Florin, L. (2013) · Journal of Virology · doi:10.1128/jvi.02906-12 · Cited by 159
“Human papillomaviruses (HPVs) are nonenveloped viruses with an icosahedral capsid containing 360 copies of the major capsid protein L1, up to 72 copies of the minor capsid protein L2 (1–5), and a double-stranded circular DNA genome (6).”
BackgroundVirus-like particles for the prevention of human papillomavirus-associated malignancies
Wang, J. W., & Roden, R. B. S. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.151 · Cited by 157
da Silva, J. R., Rodrigues, K. B., Pelegrin, G. F., Sales, N. S., Muramatsu, H., Silva, M. D. O., Porchia, B. F. M. M., Moreno, A. C. R., Aps, L. R. M. M., Venceslau-Carvalho, A. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn3464 · Cited by 164
“Therapeutic vaccines against tumors induced by HPV have targeted the E6 and E7 oncoproteins, which are specifically expressed by tumor cells after integration of HPV DNA into the host genome (4).”
BackgroundPIM, D., & BANKS, L. (2010) · APMIS · doi:10.1111/j.1600-0463.2010.02618.x · Cited by 148
New Technologies and Procedures for Cervical Cancer Screening
Cuzick, J. M., Bergeron, C., Doeberitz, M. V. K., Gravitt, P. E., Jerónimo, J., Lorincz, A. T., Meijer, C. J. L. M., Sankaranarayanan, R., Snijders, P. J. F., & Szarewski, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.088 · Cited by 167
Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia
Torres-Poveda, K., Bahena-Román, M., Madrid-González, C., Burguete-García, A. I., Bermúdez-Morales, V. H., Peralta-Zaragoza, O., & Madrid-Marina, V. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.753 · Cited by 172
Iden, M., Fye, S., Li, K., Chowdhury, T. A., Ramchandran, R., & Rader, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156274 · Cited by 149
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Ganti, K., Broniarczyk, J., Manoubi, W., Massimi, P., Mittal, S., Pim, D., Szalmas, A., Thatte, J., Thomas, M., Tomaić, V., et al. (2015) · Viruses · doi:10.3390/v7072785 · Cited by 136
“Studies in immortalized human keratinocytes that the HPV 18E6 transfected keratinocytes show an exaggerated epithelial to mesenchymal (EMT) phenotype and changes in actin cytoskeletal organization that are significantly reduced in the cells that contain HPV 18E6 PBM mutant cDNA.”
BackgroundInfluentialGuidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection
Moscicki, A., Flowers, L., Huchko, M. J., Long, M. E., MacLaughlin, K. L., Murphy, J., Spiryda, L. B., & Gold, M. A. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000468 · Cited by 155
“Steps including viral entry into the basal epithelial cells, expression of oncogenes E6 and E7 resulting in abnormal basal cell proliferation [referred to pathologically as low-grade SILs (LSIL)] and progression of cell abnormalities to higher epithelial layers [referred to as high-grade (HSIL)] due to persistent HPV…”
BackgroundGenomic Landscape of Human Papillomavirus–Associated Cancers
Rusan, M., Li, Y. Y., & Hammerman, P. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1101 · Cited by 140
Haręża, D. A., Wilczyński, J. R., & Paradowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031818 · Cited by 148
“The E6 and E7 proteins are related to functional inactivation of the main regulators of the cell cycle, tumor transformation suppressors, and activation of telomerases, while E5 enables keratinocyte differentiation and immune evasion [29,66].”
BackgroundMolecular Mechanisms of Human Papillomavirus-Induced Carcinogenesis
Lehoux, M., D’Abramo, C. M., & Archambault, J. (2009) · Public Health Genomics · doi:10.1159/000214918 · Cited by 151
“Finally, viral egress probably occurs by natural tissue desquamation and may be facilitated by the keratin network disrupting ability of E4 [34].”
BackgroundAndersson, S., Safari, H., Mints, M., Lewensohn- Fuchs, I., Gyllensten, U., & Johansson, B. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602648 · Cited by 134
Papillomaviruses in dogs and cats
Munday, J. S., Thomson, N. A., & Luff, J. (2017) · The Veterinary Journal · doi:10.1016/j.tvjl.2017.04.018 · Cited by 144
Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
Tornesello, M. L., Buonaguro, L., Rossi, P. G., & Buonaguro, F. M. (2013) · BioMed Research International · doi:10.1155/2013/519619 · Cited by 141
Mirabello, L. J., Sun, C., Ghosh, A., Rodríguez, A. C., SCHIFFMAN, M. H., Wentzensen, N., Hildesheim, A., Herrero, R., Wacholder, S., Lorincz, A. T., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs135 · Cited by 138
Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
Khodabandehlou, N., Mostafaei, S., Etemadi, A., Ghasemi, A., Payandeh, M., Hadifar, S., Norooznezhad, A. H., Kazemnejad, A., & Moghoofei, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-5286-0 · Cited by 141
“These results are consistent with our results and also with earlier studies on cervical cancer [44, 45].”
BackgroundResultRoles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health
Zhu, B., Tao, Z., Edupuganti, L., Serrano, M. G., & Buck, G. A. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00181-21 · Cited by 156
“changes that lead to cervical malignancy (155).”
Asiaf, A., Ahmad, S. T., Mohammad, S. O., & Zargar, M. A. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328364f273 · Cited by 126
“Initial infection is thought to require viral access to cells in the basal layer of the stratified epithelium through breaks, mild abrasions, or other microtraumas, as would occur during sexual intercourse or after minor skin abrasions (Doorbar, 2006; Hebner and Laimins, 2006).”
BackgroundBovine and Human Papillomaviruses
Munday, J. S. (2014) · Veterinary Pathology · doi:10.1177/0300985814537837 · Cited by 130
“PVs do not cause cell lysis, and viral particles are only released after the epithelial cell has been sloughed from the epithelial surface and degraded.(37)”
BackgroundClinical significance of human papillomavirus genotyping
Choi, Y. J., & Park, J. S. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e21 · Cited by 143
“Overexpression of viral genes results in the transformation of HPV infected cells to malignant cells [17,27,29].”
BackgroundMultiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas
Xu, B., Chotewutmontri, S., Wolf, S., Klos, U., Schmitz, M., Dürst, M., & Schwarz, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066693 · Cited by 126
“The HPV life cycle and viral gene expression patterns are severely disturbed in the course of cervical carcinogenesis [14].”
BackgroundCervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
SCHIFFMAN, M. H., & Solomon, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1210379 · Cited by 139
Chung, S.-H., Wiedmeyer, K., Shai, A., Korach, K. S., & Lambert, P. F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2051 · Cited by 120
“This is consistent with the fact that cervical cancers preferentially arise at the transformation zone of the endocervix, the site of reserve cells, and the hypothesis that reserve cells are the progenitor cell type for cervical carcinogenesis (4, 23, 39 , 40).”
Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling
van Harn, T., Foijer, F., van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H., & te Riele, H. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 124
“Moreover, human papillomavirus (HPV) can initiate cervical carcinoma and squamous cell carcinoma of the head and neck by expression of the E7 oncoprotein that inactivates the protein retinoblastoma (pRB) (Doorbar 2006; Perez-Ordonez et al. 2006).”
BackgroundHistology of cervical intraepithelial neoplasia and the role of biomarkers
Martin, C. M., & O’Leary, J. J. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.04.005 · Cited by 123
The interplay between HPV and host immunity in head and neck squamous cell carcinoma
Andersen, A. S. M., Sølling, A. S., Ovesen, T., & Rusan, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28411 · Cited by 130
Human Beta‐papillomavirus infection and keratinocyte carcinomas
Quint, K. D., Genders, R. E., de Koning, M. N., Borgogna, C., Gariglio, M., Bavinck, J. N. B., Doorbar, J., & Feltkamp, M. C. W. (2014) · The Journal of Pathology · doi:10.1002/path.4425 · Cited by 121
“In addition to its important roles in replication and transcription, E2 also has a key function in ensuring viral genome partitioning during mitosis by tethering replicated HPV episomes to the host cell chromosome [26].”
BackgroundSelf-citationZheng, L., Wu, J., & Zheng, M. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001407 · Cited by 120
“7% of cervical cancers and 80% of oropharyngeal cancers are now attributed to high-risk types of HPV.(3,4) Two international studies show the decreasing incidence rate of cervical cancer and the rising incidence rate of oropharyngeal cancer.”
BackgroundInfluentialHPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies
Dok, R., & Nuyts, S. (2016) · Cancers · doi:10.3390/cancers8040041 · Cited by 117
“a negative feedback loop, which is also used as surrogate marker for HPV infections [28,29].”
BackgroundInfluentialThe Immune Response to Papillomavirus During Infection Persistence and Regression
Hibma, M. H. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010241 · Cited by 135
“The minimum involvement is up to the basal layer of the epidermis, so that the virions can infect these dividing cells [17].”
Bergeron, C., Ronco, G., Reuschenbach, M., Wentzensen, N., Arbyn, M., Stoler, M. H., & Doeberitz, M. V. K. (2014) · International Journal of Cancer · doi:10.1002/ijc.28900 · Cited by 129
Cellular binding partners of the human papillomavirus E6 protein
Tungteakkhun, S. S., & Duerksen-Hughes, P. J. (2008) · Archives of Virology · doi:10.1007/s00705-007-0022-5 · Cited by 104
“The low levels of E6 and E7 that are seen early in the normal viral life cycle enable the initially low number of virus-infected cells to survive and expand [30].”
BackgroundIdentification of the dynein light chains required for human papillomavirus infection
Schneider, M. A., Spoden, G. A., Florin, L., & Lambert, C. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01515.x · Cited by 110
“In order to initiate replication, papillomaviruses need to deliver their circular double-stranded DNA genome into the nucleus (Doorbar, 2006).”
BackgroundBogaert, L., Martens, A., Poucke, M. V., Ducatelle, R., Cock, H. D., Dewulf, J., Baere, C. D., Peelman, L. J., & Gasthuys, F. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.11.008 · Cited by 110
“Particularly in an 350 environment which is sub-optimal for completion of the productive life cycle of 351 papillomaviruses, resulting in an abortive infection, progression to cancer is more likely to 352 happen (Doorbar, 2006).”
BackgroundGuimerà, N., Lloveras, B., Lindeman, J., Alemany, L., van de Sandt, M. M., Alejo, M., Hernandez-Suarez, G. A., Bravo, I. G., Molijn, A. C., Jenkins, D., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828b6be4 · Cited by 110
“6,7 We examined similarities in sequences of the E7 protein between the LR-HPVs and those of HR-HPVs and related them to p16 expression as a marker for transforming HR-HPV E7 gene expression.(8,9) We show that oncogenic mechanisms of HPV42 and 70 may be similar to HR-HPV and are associated with a typical squamous cell…”
MethodThe role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma
Berti, F. C. B., Pereira, A. P. L., Cebinelli, G. C. M., Trugilo, K. P., & de Oliveira, K. B. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.002 · Cited by 118
“The URR has approximately 1000 bp, separating the early and late regions, and contains the origin of DNA replication as well as several sequences such as transcription factorbinding sites that are involved in protein expression regulation [1,9].”
BackgroundCervical Cancer Markers: Epigenetics and microRNAs
Laengsri, V., Kerdpin, U., Plabplueng, C. D., Treeratanapiboon, L., & Nuchnoi, P. (2017) · Laboratory Medicine · doi:10.1093/labmed/lmx080 · Cited by 113
Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese Women
Chen, X., Han, S., Wang, S., Zhou, X., Zhang, M., Dong, J., Shi, X., 钱年凤, Wang, X., Wei, Q., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1829 · Cited by 112
Pinheiro, C. M., Longatto‐Filho, A., Ferreira, L., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31817b5b40 · Cited by 103
“Thus, we can speculate that HPV infection may, by some mechanism, stimulate MCT1 and MCT4 expressions as well as trafficking of MCT1 to the plasma membrane, but not MCT2 expression, probably with the purpose of favoring higher glycolytic rates during tumorigenesis, as HPV stimulates cell proliferation (26,27).”
BackgroundWheeler, C. M. (2008) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.09.006 · Cited by 132
“The E6 and E7 ORFs encode what have been described as the primary HPV transforming or oncoproteins.(3,4) The retinoblastoma tumor suppressor protein (pRB) and p53 are the two host proteins whose”
BackgroundNovel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
Cohen, A. C., Roane, B. M., & Leath, C. A. (2020) · Drugs · doi:10.1007/s40265-019-01249-z · Cited by 108
Xue, Y., Bellanger, S., Zhang, W., Lim, D. G. S., Low, J. J. H., Lunny, D. P., & Thierry, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3789 · Cited by 100
“The functions of the viral proteins and regulation of transcription and replication of the viral genome have been extensively studied in cell cultures and differentiated keratinocytes in raft cultures in vitro (19, 24).”
BackgroundLi, J., Xiao, X., Zhang, Y.-N., Wang, Y., Feng, L., Wu, Y., & Zhang, Y. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.09.009 · Cited by 106
Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
Muñoz-Bello, J. O., Olmedo‐Nieva, L., Contreras‐Paredes, A., Gonzalez, A., Rocha‐Zavaleta, L., & Lizano, M. (2015) · Viruses · doi:10.3390/v7082842 · Cited by 115
“The HPV genome consists of a double-stranded circular DNA of approximately 8000 bp that contains genes that are expressed early (E) or late (L) during the viral life cycle and whose transcription and replication are mediated by the long control region (LCR) [76].”
BackgroundGrabowska, A. K., & Riemer, A. B. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010249 · Cited by 101
“Thus, HPV infection does not elicit any danger signals, which would be crucial for activation and trafficking of antigen presenting cells (APCs), production of proinflammatory cytokines and initiation of adaptive immune responses [12, 14].”
InfluentialHuman Papillomavirus Genomics: Past, Present and Future
Harari, A., Chen, Z., & Burk, R. D. (2014) · Current problems in dermatology · doi:10.1159/000355952 · Cited by 118
Liu, J., Wang, D., Long, Z., Liu, J., & Li, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491716 · Cited by 98
Association of High Risk Human Papillomavirus and Breast cancer: A UK based Study
Salman, N. A., Davies, G., Majidy, F., Shakir, F., Akinrinade, H., Perumal, D., & Ashrafi, G. H. (2017) · Scientific Reports · doi:10.1038/srep43591 · Cited by 112
Human papillomaviruses and the specificity of PDZ domain targeting
Pim, D., Bergant, M., Boon, S. S., Ganti, K., Kranjec, C., Massimi, P., Subbaiah, V. K., Thomas, M., Tomaić, V., & Banks, L. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08709.x · Cited by 94
Chang, J., Kuo, T.-F., Chen, Y., Chiu, C.-C., Lu, Y.-C., Li, H.-F., Shen, C.-R., & Cheng, A.-J. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.38 · Cited by 103
Targeted treatments for cervical cancer: a review
Peralta-Zaragoza, Ó., Bermudez-Morales, Pérez‐Plasencia, C., Salazar-Leon, Gómez-Cerón, C., & Madrid-Marina, V. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s25123 · Cited by 106
“However, when HPV DNA binds to host cellular DNA, it is in the integrate conformation, which is found in high-grade squamous intraepithelial lesions and invasive carcinomas.(4) An early event in HPV-associated carcinogenesis during HPV DNA integration is the Dovepress”
BackgroundTetraspanins - Gateways for Infection
Monk, P. N., & Partridge, L. J. (2012) · Infectious Disorders - Drug Targets · doi:10.2174/187152612798994957 · Cited by 107
“Human papillomavirus type 16, a papillomaviridae, is a non-enveloped dsDNA virus that is linked to carcinoma of the female genital tract [129].”
BackgroundBéziat, V., Rapaport, F., Hu, J., Titeux, M., Bonnet des Claustres, M., Bourgey, M., Griffin, H., Bandet, É., Ma, C. S., Sherkat, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.004 · Cited by 95
Self-citationEmerging human papillomavirus vaccines
Ma, B., Maraj, B., Tran, N. P., Knoff, J. S., Chen, A. J., Alvarez, R. D., Hung, C., & Wu, T. ‐. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.744393 · Cited by 104
“The major capsid protein (L1) and minor capsid protein (L2) are involved in packaging the virion before extracellular release (for review, see [11]).”
BackgroundAnalyses of human papillomavirus genotypes and viral loads in anogenital warts
Ball, S. L. R., Winder, D. M., Vaughan, K., Hanna, N., Lévy, J., Sterling, J. C., Stanley, M., & Goon, P. K. C. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22111 · Cited by 94
“The choice of E6/E7 transcript in this study was based on their known roles in the viral infectious cycle [Doorbar, 2006].”
BackgroundHuman Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance
Scott, M. L., Woodby, B. L., Ulicny, J., Raikhy, G., Orr, A. W., Songock, W. K., & Bodily, J. M. (2020) · Journal of Virology · doi:10.1128/jvi.01582-19 · Cited by 87
“immune system in order to persist (1, 5, 6).”
Background
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.